.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Fuji
Colorcon
Healthtrust
Merck
Teva
UBS
QuintilesIMS
Express Scripts

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065327

« Back to Dashboard

NDA 065327 describes CEFPROZIL, which is a drug marketed by Apotex Inc, Aurobindo Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, Sandoz, Teva Pharms, Aurobindo Pharma Ltd, Teva, and Wockhardt, and is included in fifteen NDAs. It is available from nineteen suppliers. Additional details are available on the CEFPROZIL profile page.

The generic ingredient in CEFPROZIL is cefprozil. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cefprozil profile page.

Summary for 065327

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 065327

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFPROZIL cefprozil TABLET;ORAL 065327 ANDA Apotex Corp 60505-2532 60505-2532-8 1000 TABLET, FILM COATED in 1 BOTTLE (60505-2532-8)
CEFPROZIL cefprozil TABLET;ORAL 065327 ANDA Apotex Corp 60505-2532 60505-2532-3 30 TABLET, FILM COATED in 1 BOTTLE (60505-2532-3)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Mar 26, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Mar 26, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
Merck
Chubb
Johnson and Johnson
Mallinckrodt
Cerilliant
Cantor Fitzgerald
Cipla
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot